# COPD 



## Inhalers


### Triple Inhalers

No increase in exacerbation risk for patients stable on triple inhalers (who do not have asthma or eosinophils over 300) to take off the ICS

- this is advantageous due to increased risk of severe pneumonia
- example of Pharmd led de-prescribing initiative: https://www.atsjournals.org/doi/full/10.1513/AnnalsATS.202007-871RL
